MGMT and central nervous system cancer: Radiographically, gliomas with MGMT promoter methylation have been associated with less vasogenic edema, higher ADC values, and lower cerebral blood flow and blood volume on MR PWI, relative to unmethylated tumors according to a meta-analysis of relevant studies (Suh et al., 2019).